Overview
- Simo announced on Thursday that she will not return to full‑time work and will become a part‑time adviser after a months‑long medical leave for postural orthostatic tachycardia syndrome (POTS).
- Her April medical leave followed a severe relapse that she has said made recovery longer and more complex than expected.
- OpenAI shifted product and business duties while Simo was out, with president Greg Brockman taking charge of product strategy and other senior leaders assuming redistributed responsibilities.
- The company confidentially filed IPO paperwork in June and Simo’s exit intensifies investor and governance questions that analysts say could push a public listing toward 2027.
- OpenAI is pressing product consolidation — including a major ChatGPT agent update — even as Simo’s move removes a leader who had driven consumer, enterprise and health care plans and who co‑founded ChronicleBio to advance neuroimmune research.